Westpac Banking Corp Vertex Pharmaceuticals Inc Transaction History

Westpac Banking Corp

$1.49 Trillion
Q3 2024

A detailed history of Westpac Banking Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Westpac Banking Corp holds 3,406 shares of VRTX stock, worth $1.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,406

Previous 3,278 3.9%

Holding current value

$1.6 Million

Previous $1.54 Billion 3.1%

% of portfolio

0.11%

Previous 0.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$460.0 - $505.78 $58,880 - $64,739	128 Added 3.9%	3,406 $1.58 Billion
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $902,284 - $1.12 Million	2,297 Added 234.15%	3,278 $1.54 Billion
Q2 2024 Aug 12, 2024	SELL	$392.81 - $485.53 $752,623 - $930,275	-1,916 Reduced 66.14%	981 $1.54 Billion
Q1 2024 May 09, 2024	SELL	$407.69 - $446.08 $268,667 - $293,966	-659 Reduced 18.53%	2,897 $1.21 Billion
Q4 2023 Feb 08, 2024	BUY	$343.0 - $410.68 $28,469 - $34,086	83 Added 2.39%	3,556 $1.45 Billion
Q3 2023 Nov 09, 2023	SELL	$338.18 - $362.46 $1.04 Million - $1.11 Million	-3,076 Reduced 46.97%	3,473 $1.21 Billion
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $12 Million - $13.4 Million	-38,130 Reduced 85.34%	6,549 $2.3 Billion
Q1 2023 May 03, 2023	SELL	$283.23 - $323.1 $1.51 Million - $1.73 Million	-5,349 Reduced 10.69%	44,679 $14.1 Billion
Q4 2022 Feb 06, 2023	BUY	$285.76 - $321.48 $3.95 Million - $4.44 Million	13,809 Added 38.13%	50,028 $14.4 Billion
Q3 2022 Nov 08, 2022	SELL	$273.83 - $305.53 $1.05 Million - $1.18 Million	-3,850 Reduced 9.61%	36,219 $10.5 Billion
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $352,909 - $439,410	-1,502 Reduced 3.61%	40,069 $11.3 Billion
Q1 2022 May 11, 2022	BUY	$221.42 - $260.97 $3.45 Million - $4.06 Million	15,571 Added 59.89%	41,571 $10.8 Million
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $12,921 - $16,311	-73 Reduced 0.28%	26,000 $5.71 Billion
Q3 2021 Oct 27, 2021	SELL	$181.39 - $202.99 $7.72 Million - $8.64 Million	-42,566 Reduced 62.01%	26,073 $4.73 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $851,579 - $1 Million	4,542 Added 7.09%	68,639 $13.8 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $74,320 - $86,630	359 Added 0.56%	64,097 $13.8 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $5.62 Million - $7.49 Million	27,140 Added 74.16%	63,738 $15.1 Million
Q3 2020 Nov 10, 2020	BUY	$255.65 - $303.1 $839,810 - $995,683	3,285 Added 9.86%	36,598 $9.96 Million
Q2 2020 Aug 12, 2020	SELL	$225.48 - $295.8 $1.33 Million - $1.74 Million	-5,899 Reduced 15.04%	33,313 $9.67 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $2.94 Million - $3.64 Million	14,704 Added 60.0%	39,212 $9.33 Million
Q4 2019 Feb 11, 2020	BUY	$166.71 - $223.91 $352,758 - $473,793	2,116 Added 9.45%	24,508 $5.37 Million
Q2 2019 Aug 01, 2019	SELL	$164.61 - $190.37 $7.81 Million - $9.04 Million	-47,461 Reduced 67.94%	22,392 $0
Q1 2019 May 14, 2019	SELL	$163.73 - $194.7 $6.19 Million - $7.36 Million	-37,819 Reduced 35.12%	69,853 $0
Q4 2018 Feb 07, 2019	SELL	$151.91 - $192.21 $950,348 - $1.2 Million	-6,256 Reduced 5.49%	107,672 $17.8 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $3.13 Million - $3.59 Million	-18,638 Reduced 14.06%	113,928 $0
Q2 2018 Jul 18, 2018	SELL	$145.72 - $169.96 $84,080 - $98,066	-577 Reduced 0.43%	132,566 $0
Q1 2018 May 01, 2018	BUY	$151.6 - $177.13 $2.58 Million - $3.01 Million	16,991 Added 14.63%	133,143 $0
Q4 2017 Jan 18, 2018	BUY	$137.28 - $155.55 $5.5 Million - $6.24 Million	40,100 Added 52.73%	116,152 $0
Q3 2017 Oct 30, 2017	BUY	$148.13 - $162.24 $11.3 Million - $12.3 Million	76,052	76,052 $0

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Account

Westpac Banking Corp Vertex Pharmaceuticals Inc Transaction History